Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
Clinical trial NCT00164892 · UNKNOWN
Trial details
- NCT number
- NCT00164892
- Sponsor
- Chinese University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.